Data supplements
Supplemental Data
Files in this Data Supplement:
Jump to section
- Article
- Abstract
- CLINICAL GUIDELINES FOR THE DIAGNOSIS OF AD AND DEMENTIA AND THE ROLE OF IMAGING
- OBJECTIVES OF THIS REVIEW
- 18F-FDG PET CROSS-SECTIONAL CASE-CONTROL STUDIES USING CLINICAL ASSESSMENT AS DIAGNOSTIC REFERENCE STANDARD
- 18F-FDG PET STUDIES USING LONGITUDINAL CLINICAL FOLLOW-UP ASSESSMENT AS DIAGNOSTIC REFERENCE STANDARD
- 18F-FDG PET STUDIES OF AD AND DEMENTIA USING PATHOLOGIC CONFIRMATION AS THE REFERENCE STANDARD
- 18F-FDG PET DIFFERENTIAL DIAGNOSIS OF AD VERSUS OTHER DEMENTIAS
- LARGE MULTICENTER STUDIES
- PHYSICIAN CONFIDENCE LEVEL AND PREDICTIVE VALUE OF 18F-FDG PET
- COMPUTER-ASSISTED QUANTITATIVE INTERPRETATION OF BRAIN 18F-FDG PET
- PATHOPHYSIOLOGY OF 18F-FDG METABOLISM AND INVESTIGATIONAL STUDIES
- SAFETY
- LIMITATIONS
- TEMPORAL PROFILE OF 18F-FDG PET IN RELATIONSHIP TO OTHER BIOMARKERS OF AD
- LITERATURE REVIEW AND COMMENTS
- CONCLUSION
- Acknowledgments
- Footnotes
- REFERENCES
- Figures & Data
- Supplemental
- Info & Metrics
Related Articles
Cited By...
- Perfusion CT imaging as a diagnostic and prognostic tool for dementia: prospective case-control study
- Amyloid PET in Dementia Syndromes: A Chinese Multicenter Study
- Integrity of Neurocognitive Networks in Dementing Disorders as Measured with Simultaneous PET/Functional MRI
- Predictive Value of 18F-Florbetapir and 18F-FDG PET for Conversion from Mild Cognitive Impairment to Alzheimer Dementia
- Limits for Reduction of Acquisition Time and Administered Activity in 18F-FDG PET Studies of Alzheimer Dementia and Frontotemporal Dementia
- Development and validation of a deep learning framework for Alzheimers disease classification
- FDG-PET patterns associated with underlying pathology in corticobasal syndrome
- 18F-FDG and Amyloid PET in Dementia
- Time Courses of Cortical Glucose Metabolism and Microglial Activity Across the Life Span of Wild-Type Mice: A PET Study
- Resting-State Networks as Simultaneously Measured with Functional MRI and PET
- 18F-FDG PET Improves Diagnosis in Patients with Focal-Onset Dementias
- Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer's Disease
- Noninvasive imaging of immune responses
- American College of Radiology and Society of Nuclear Medicine and Molecular Imaging Joint Credentialing Statement for PET/MR Imaging: Brain
- Mapping Changes in Mouse Brain Metabolism with PET/CT
- Potential for misdiagnosis in community-acquired PET scans for dementia
- Loss of Olfactory Tract Integrity Affects Cortical Metabolism in the Brain and Olfactory Regions in Aging and Mild Cognitive Impairment
- Imaging markers for Alzheimer disease: Which vs how
- PET/MRI for Neurologic Applications
- FDG-PET and molecular brain imaging in the movement disorders clinic
- Nuclear medicine functional imaging of the brain
- Diagnostic tests for Alzheimer disease: FDG-PET imaging is a player in search of a role
- Diagnostic tests for Alzheimer disease: Judicious use can be helpful in clinical practice